Research study Program year 2022 Source: CMS Open Payments

Patisiran US-only Expanded Access Program

Research payments

$250,064

20 payments

Through program year 2022, $250,064 in research payments was reported against Patisiran US-only Expanded Access Program, across 20 payments, paid by Alnylam Pharmaceuticals Inc..

Paid by: Alnylam Pharmaceuticals Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2022	Research	$250,064	20

Breakdown

Who paid Research payments · program year 2022

Alnylam Pharmaceuticals Inc. $250,064 20 payments

Who received the money Research payments · program year 2022

Ohio Health Organisation paid for research $33,352 5 payments
U Of Utah Neuropsychiatric Institute Teaching hospital · UT $25,149 1 payment
Cedars-Sinai Medical Center Teaching hospital · CA $24,060 1 payment
Baylor Scott and White Organisation paid for research $21,507 1 payment
The Trustees of Columbia Univ. in the City of New York Organisation paid for research $20,550 1 payment
Washington University School Of Medicine Organisation paid for research $20,417 1 payment
University of Chicago Organisation paid for research $19,260 1 payment
The University of Nebraska Medical Center Organisation paid for research $18,936 1 payment
Cleveland Clinic Hospital Teaching hospital · OH $18,020 3 payments
University Of Kansas Medical Center Research Institute Organisation paid for research $17,603 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.